Rundu shares: passed the GMP certification of the Brazilian National Health Surveillance Agency
Rundu shares announced that the company accepted the on-site GMP certification of the Brazilian National Health Surveillance Agency from March 17, 2025 to March 21, 2025, and the certification scope was chemical raw materials: candesartan cilexetil, sacubitril valsartan sodium, telmisartan, and valsartan. Recently, the company received two GMP certification certificates issued by Brazil's ANVISA, which are valid until May 26, 2027 and June 9, 2027. The conclusion of the on-site inspection by Brazil's ANVISA is qualified, that is, the company's four raw material products have passed the Brazilian ANVISA on-site GMP certification.